去年，Neuronetics Inc表现最佳的业务板块Clinic revenue实现营收86.98M美元。United States的营收贡献最高，去年达到146.05M美元。最近一个季度，截至2026-03-31，Neuronetics Inc表现最佳的业务板块Clinic revenue实现营收21.53M美元。United States的营收贡献最高，达到40.57M美元。

业务

营业收入

占比

年报

年报

单季报

Clinic revenue

Treatment sessions

NeuroStar Advanced Therapy System

Other

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

Clinic revenue

86.98M(58.31%)

--(--)

Treatment sessions

44.41M(29.77%)

51.45M(73.03%)

51.65M(72.39%)

45.43M(69.67%)

42.20M(76.29%)

35.30M(71.69%)

41.47M(66.18%)

NeuroStar Advanced Therapy System

15.54M(10.42%)

16.09M(22.84%)

17.09M(23.95%)

17.39M(26.66%)

10.87M(19.65%)

11.95M(24.27%)

19.11M(30.50%)

Other

2.24M(1.50%)

2.91M(4.13%)

2.61M(3.66%)

2.39M(3.66%)

2.25M(4.06%)

1.99M(4.05%)

2.08M(3.31%)

地区

营业收入

占比

年报

年报

单季报

United States

International

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

United States

146.05M(97.92%)

68.04M(96.59%)

69.34M(97.18%)

63.41M(97.24%)

53.45M(96.63%)

47.52M(96.50%)

60.76M(96.97%)

51.48M(97.54%)

39.85M(98.57%)

31.58M(92.25%)

International

3.11M(2.08%)

2.40M(3.41%)

2.01M(2.82%)

1.80M(2.76%)

1.86M(3.37%)

1.73M(3.50%)

1.90M(3.03%)

1.30M(2.46%)

580.00K(1.43%)

2.65M(7.75%)